Distance and Intermediate Visual Acuity in Patients With Implanted Monofocal Negative Aspheric Intraocular Lens
CLAINT
1 other identifier
interventional
100
1 country
3
Brief Summary
To get the visual outcomes for distance and intermediate and binocular defocus curve in patients with implanted monofocal intraocular lens Clareon (IOL; model SY60CL; Alcon Vision LLC) at 3 months after the surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2022
Shorter than P25 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2022
CompletedFirst Submitted
Initial submission to the registry
January 15, 2023
CompletedFirst Posted
Study publicly available on registry
January 26, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2023
CompletedFebruary 23, 2023
February 1, 2023
7 months
January 15, 2023
February 21, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Monocular corrected Distance Visual Acuity (CDVA)
Monocular corrected distance visual acuity (CDVA) is measured at 4 m using an ETDRS (Early Treatment Diabetic Retinopathy Study) illumination cabinet (Precision Vision) under photopic conditions.
3 months
Binocular corrected Distance Visual Acuity (CDVA)
Binocular corrected distance visual acuity (CDVA) is measured at 4 m using an ETDRS (Early Treatment Diabetic Retinopathy Study) illumination cabinet (Precision Vision) under photopic conditions.
3 months
Monocular uncorrected intermediate visual acuity (UIVA)
Monocular intermediate visual acuity is measured using printed ETDRS charts for distance of 66cm
3 months
Binocular uncorrected intermediate visual acuity (UIVA)
Binocular intermediate visual acuity is measured using printed ETDRS charts for distance of 66cm
3 months
Monocular distance corrected intermediate visual acuity (DCIVA)
Monocular distance corrected intermediate visual acuity is measured using printed ETDRS charts for distance of 66cm
3 months
Binocular distance corrected intermediate visual acuity (DCIVA)
Binocular distance corrected intermediate visual acuity is measured using printed ETDRS charts for distance of 66cm
3 months
Secondary Outcomes (1)
Binocular defocus curve
3 months
Study Arms (1)
Monofocal lens
OTHEREyes of patients with implanted monofocal aspheric lens Clareon (Alcon LLC)
Interventions
monofocal aspheric lens implanted in eyes of patient during routine cataract surgery
Eligibility Criteria
You may qualify if:
- presence of cataract in both eyes
- no other ocular pathology affecting visual acuity
- bilateral phacoemulsification cataract surgery was arranged for both eyes
- corneal astigmatism up to 0,5 cylinder (measured by IOL Master biometry)
- dioptric power of both selective lens within 1,5 D range in one patient
- selecting IOL power between 15 D and 28 D power range
You may not qualify if:
- complicated cataract
- corneal opacities or irregularities
- amblyopia
- anisometropia
- coexisting ocular pathologies
- glaucoma
- history of ocular surgery
- refusal or unable to maintain follow-up
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Faculty Hospital Kralovske Vinohradylead
- Očni centrum Praha a.s.collaborator
- Somich, s.r.o.collaborator
Study Sites (3)
Eye Center Prague
Prague, Czech Republic, 11000, Czechia
Faculty hospital Kralovske Vinohrady
Prague, Czech Republic, 11000, Czechia
Somich Eye Clinic
Karlovy Vary, 36001, Czechia
Related Publications (3)
Lehmann R, Maxwell A, Lubeck DM, Fong R, Walters TR, Fakadej A. Effectiveness and Safety of the Clareon Monofocal Intraocular Lens: Outcomes from a 12-Month Single-Arm Clinical Study in a Large Sample. Clin Ophthalmol. 2021 Apr 20;15:1647-1657. doi: 10.2147/OPTH.S295008. eCollection 2021.
PMID: 33907378RESULTWerner L, Thatthamla I, Ong M, Schatz H, Garcia-Gonzalez M, Gros-Otero J, Canones-Zafra R, Teus MA. Evaluation of clarity characteristics in a new hydrophobic acrylic IOL in comparison to commercially available IOLs. J Cataract Refract Surg. 2019 Oct;45(10):1490-1497. doi: 10.1016/j.jcrs.2019.05.017. Epub 2019 Aug 6.
PMID: 31399323RESULTBala C, Poyales F, Guarro M, Mesa RR, Mearza A, Varma DK, Jasti S, Lemp-Hull J. Multicountry clinical outcomes of a new nondiffractive presbyopia-correcting IOL. J Cataract Refract Surg. 2022 Feb 1;48(2):136-143. doi: 10.1097/j.jcrs.0000000000000712.
PMID: 34288635RESULT
Study Officials
- PRINCIPAL INVESTIGATOR
Andrea Janekova, MD
Eye Center Prague
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Masking Details
- no masking
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 15, 2023
First Posted
January 26, 2023
Study Start
October 1, 2022
Primary Completion
May 1, 2023
Study Completion
August 1, 2023
Last Updated
February 23, 2023
Record last verified: 2023-02
Data Sharing
- IPD Sharing
- Will not share